INFIQ — Infinity Pharmaceuticals Balance Sheet
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
- $0.00m
- -$17.75m
- $2.59m
Annual balance sheet for Infinity Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 58.6 | 42.4 | 34.1 | 80.7 | 38.3 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 59.8 | 44.6 | 36 | 82.3 | 40.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.028 | 3.9 | 3.13 | 2.31 | 1.5 |
Other Long Term Assets | |||||
Total Assets | 60.2 | 49 | 39.3 | 84.8 | 42.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 7.72 | 9.7 | 11 | 13.3 | 13.6 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.76 | 41.3 | 62.3 | 63.2 | 61.2 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 52.5 | 7.73 | -23 | 21.6 | -19.1 |
Total Liabilities & Shareholders' Equity | 60.2 | 49 | 39.3 | 84.8 | 42.2 |
Total Common Shares Outstanding |